Search research articles
Contact Us
Filters
Showing results (1-10 of 93) with videos related to
Page
of 10
Sort By:
JAMA Oncology
|
September 24, 2020
Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge-Reply
Charles Dolladille, Angélique Da-Silva, Joachim Alexandre
European Journal of Heart Failure
|
July 30, 2019
Takotsubo syndrome in patients with cancer treated with immune checkpoint inhibitors: a new adverse cardiac complication
Stephane Ederhy, Charles Dolladille, Franck Thuny, et al.
Circulation
|
January 25, 2021
Cardiovascular Toxicities Associated With Loperamide: Analysis of the World Health Organization Pharmacovigilance Database
Pierre Ollitrault, Charles Dolladille, Basile Chrétien, et al.
Journal of the American College of Cardiology
|
October 18, 2023
Loperamide-Associated Ventricular Arrhythmias
Jonaz Font, Joachim Alexandre, Charles Dolladille, et al.
Journal of the American College of Cardiology
|
January 26, 2019
Fluoroquinolone and Aortic Dissection: Is It a Class Effect?
Charles Dolladille, Basile Chrétien, Marion Sassier, et al.
Psychological Medicine
|
July 9, 2020
Response to 'The association of clozapine and haematological malignancies needs to be replicated by other studies and more importantly by analyses of subsamples from VigiBase'
Basile Chrétien, Véronique Lelong-Boulouard, Joachim Alexandre, et al.
Children (Basel, Switzerland)
|
December 23, 2023
State of the Art of Probiotic Use in Neonatal Intensive Care Units in French-Speaking European Countries
Amélie Blanchetière, Charles Dolladille, Isabelle Goyer, et al.
Therapie
|
April 7, 2024
Impact of the vaccination against SARS-CoV-2 campaign on disproportionality indicator from the WHO pharmacovigilance database: A competition bias study from case/non-case analysis
Francis Adjaï, Dorine Fournier, Charles Dolladille, et al.
BMJ Open
|
December 3, 2024
Immune checkpoint inhibitor rechallenge after immune-related adverse events: a retrospective study from VigiBase update in 2024 looking for emergent safety signals
Jean-Matthieu L'Orphelin, Angélique Da Silva, Jean Cabon, et al.
Journal of the American College of Cardiology
|
September 22, 2018
Cocaine and/or Marijuana Use and Myocardial Infarction
Basile Chrétien, Reynald Le Boisselier, Charles Dolladille, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 93) with videos related to
Sort By:
Page
of 10
JAMA Oncology
|
September 24, 2020
Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge-Reply
Charles Dolladille, Angélique Da-Silva, Joachim Alexandre
European Journal of Heart Failure
|
July 30, 2019
Takotsubo syndrome in patients with cancer treated with immune checkpoint inhibitors: a new adverse cardiac complication
Stephane Ederhy, Charles Dolladille, Franck Thuny, et al.
Circulation
|
January 25, 2021
Cardiovascular Toxicities Associated With Loperamide: Analysis of the World Health Organization Pharmacovigilance Database
Pierre Ollitrault, Charles Dolladille, Basile Chrétien, et al.
Journal of the American College of Cardiology
|
October 18, 2023
Loperamide-Associated Ventricular Arrhythmias
Jonaz Font, Joachim Alexandre, Charles Dolladille, et al.
Journal of the American College of Cardiology
|
January 26, 2019
Fluoroquinolone and Aortic Dissection: Is It a Class Effect?
Charles Dolladille, Basile Chrétien, Marion Sassier, et al.
Psychological Medicine
|
July 9, 2020
Response to 'The association of clozapine and haematological malignancies needs to be replicated by other studies and more importantly by analyses of subsamples from VigiBase'
Basile Chrétien, Véronique Lelong-Boulouard, Joachim Alexandre, et al.
Children (Basel, Switzerland)
|
December 23, 2023
State of the Art of Probiotic Use in Neonatal Intensive Care Units in French-Speaking European Countries
Amélie Blanchetière, Charles Dolladille, Isabelle Goyer, et al.
Therapie
|
April 7, 2024
Impact of the vaccination against SARS-CoV-2 campaign on disproportionality indicator from the WHO pharmacovigilance database: A competition bias study from case/non-case analysis
Francis Adjaï, Dorine Fournier, Charles Dolladille, et al.
BMJ Open
|
December 3, 2024
Immune checkpoint inhibitor rechallenge after immune-related adverse events: a retrospective study from VigiBase update in 2024 looking for emergent safety signals
Jean-Matthieu L'Orphelin, Angélique Da Silva, Jean Cabon, et al.
Journal of the American College of Cardiology
|
September 22, 2018
Cocaine and/or Marijuana Use and Myocardial Infarction
Basile Chrétien, Reynald Le Boisselier, Charles Dolladille, et al.
Page
of 10